Jay Moorin, Partner

Mr. Moorin is a founding General Partner of ProQuest Investments, which currently manages over $900 million in four healthcare venture capital funds. He is a healthcare executive with senior management experience in the biotech, investment banking and pharmaceutical industries. Prior to founding ProQuest, Mr. Moorin served as Chairman of the Board and CEO of Magainin Pharmaceuticals, a publicly-traded biopharmaceutical company. Previously, served as managing director of healthcare banking at Bear Stearns & Co. Inc. and vice president of marketing and business development at a division of the ER Squibb Pharmaceutical Company. Mr. Moorin serves on the board of Eagle Pharmaceuticals Inc., is an advisor to DPT Capital Management, LLC, an investment firm, and serves as a trustee of the Equinox Funds Trust. He has served on the Board of Directors of ACMI, Acurian, Aires Pharmaceuticals, Epic Therapeutics, Gloucester Pharmaceuticals, Guava Technologies, Mersana Therapeutics, MethylGene, Novacea, Pharmion and Predictive Biosciences. Mr. Moorin held the position of adjunct senior fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania from 1997 to 2012. Previously, Mr. Moorin served on the board of directors of numerous public and private healthcare companies. Mr. Moorin holds a B.A. from the University of Michigan.